Asahi Kasei and Asahi Kasei Medical announced the opening of the Asahi Kasei (China) Bioprocess Technical Center (CBTC) in Suzhou, Jiangsu, China. Accordingly, the bioprocess business of Asahi Kasei Medical is one of the “10 Growth Gears (GG10)” to drive future growth.

Asahi Kasei’s bioprocess business comprised of bioprocess-related products used in the manufacture of biotherapeutics. In addition, it also include biosafety testing services and biopharmaceutical CDMO business.

Core Technology of the Group

As an affiliate of Asahi Kasei Medical, Asahi Kasei Bioprocess (Shanghai) Co., Ltd. (AKBC) performs the import and sale of Planova™ virus removal filters, BioOptimal™ microfilters, and related equipment, to pharmaceutical companies in China. Moreover, as an affiliate of Asahi Kasei, Asahi Kasei Microza (Hangzhou) Co., Ltd. (AKMH) performs marketing in China for Microza™ modules based on hollow-fiber filtration, which is a core technology of the Asahi Kasei Group.

Asahi Kasei and Asahi Kasei Medical established CBTC to provide greater value to customers in the Chinese pharmaceutical industry. Particularly, by performing practical tests and technical support with both bioprocess products and Microza™ products, combining the strengths of the two businesses to meet customer needs.

The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics, while further leveraging Asahi Kasei’s high-level technology for ultrafiltration and microfiltration.